Healthcare provider profile · identity verified

Basem Fanous, MD

Internal Medicine · SYLMAR, CA · NPI 1619072600

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	634	168
Rosuvastatin Calcium	Rosuvastatin Calcium	413	112
Levothyroxine Sodium	Levothyroxine Sodium	346	73
Amlodipine Besylate	Amlodipine Besylate	279	82
Gabapentin	Gabapentin	207	53
Pantoprazole Sodium	Pantoprazole Sodium	205	58
Omeprazole	Omeprazole	200	53
Metoprolol Succinate	Metoprolol Succinate	199	46
Tamsulosin Hcl	Tamsulosin Hcl	197	44
Losartan Potassium	Losartan Potassium	171	45
Janumet Xr	Sitagliptin Phos/Metformin Hcl	167	33
Hydrochlorothiazide	Hydrochlorothiazide	163	46
Benazepril Hcl	Benazepril Hcl	153	36
Albuterol Sulfate Hfa	Albuterol Sulfate	147	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	145	31
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	144	31
Lisinopril	Lisinopril	137	42
Metformin Hcl	Metformin Hcl	136	46
Escitalopram Oxalate	Escitalopram Oxalate	130	30
Eliquis	Apixaban	127	31
Furosemide	Furosemide	125	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	123	39
Metformin Hcl Er	Metformin Hcl	119	37
Famotidine	Famotidine	111	21
Nebivolol Hcl	Nebivolol Hcl	110	31
Simvastatin	Simvastatin	109	32
Azelastine Hcl	Azelastine Hcl	106	33
Montelukast Sodium	Montelukast Sodium	103	16
Hydralazine Hcl	Hydralazine Hcl	101	26
Ozempic	Semaglutide	99	16
Mirtazapine	Mirtazapine	95	15
Metoprolol Tartrate	Metoprolol Tartrate	94	24
Farxiga	Dapagliflozin Propanediol	93	23
Tramadol Hcl	Tramadol Hcl	93	21
Baclofen	Baclofen	92	12
Olmesartan Medoxomil	Olmesartan Medoxomil	92	30
Divalproex Sodium	Divalproex Sodium	88	12
Valsartan	Valsartan	88	29
Allopurinol	Allopurinol	87	22
Linzess	Linaclotide	87	19
Sertraline Hcl	Sertraline Hcl	82	18
Carvedilol	Carvedilol	79	22
Levetiracetam	Levetiracetam	79	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	77	25
Buspirone Hcl	Buspirone Hcl	77	15
Jardiance	Empagliflozin	77	23
Ibandronate Sodium	Ibandronate Sodium	76	23
Glipizide Er	Glipizide	74	23
Januvia	Sitagliptin Phosphate	74	17
Finasteride	Finasteride	73	17
Prolia	Denosumab	72	46
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	67	22
Diazepam	Diazepam	63	suppressed
Trazodone Hcl	Trazodone Hcl	63	15
Fluticasone Propionate	Fluticasone Propionate	61	26
Quetiapine Fumarate	Quetiapine Fumarate	60	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	58	16
Duloxetine Hcl	Duloxetine Hcl	58	16
Potassium Chloride	Potassium Chloride	55	12
Enulose	Lactulose	51	suppressed
Pregabalin	Pregabalin	49	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	44	12
Atenolol	Atenolol	43	13
Carbamazepine	Carbamazepine	43	suppressed
Glycopyrrolate	Glycopyrrolate	43	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	39	13
Mounjaro	Tirzepatide	39	11
Pravastatin Sodium	Pravastatin Sodium	39	11
Novolog Flexpen	Insulin Aspart	38	13
Latanoprost	Latanoprost	37	suppressed
Topiramate	Topiramate	37	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	37	14
Entresto	Sacubitril/Valsartan	36	suppressed
Humalog Kwikpen U-100	Insulin Lispro	36	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	36	11
Benztropine Mesylate	Benztropine Mesylate	35	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	35	suppressed
Bumetanide	Bumetanide	35	suppressed
Clonazepam	Clonazepam	35	suppressed
Fenofibrate	Fenofibrate	35	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	35	suppressed
Dapagliflozin	Dapagliflozin Propanediol	34	12
Methenamine Hippurate	Methenamine Hippurate	34	suppressed
Alendronate Sodium	Alendronate Sodium	33	13
Arnuity Ellipta	Fluticasone Furoate	33	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	33	12
Alprazolam	Alprazolam	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	suppressed
Phenobarbital	Phenobarbital	32	suppressed
Rybelsus	Semaglutide	32	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	31	suppressed
Glimepiride	Glimepiride	31	suppressed
Repaglinide	Repaglinide	31	suppressed
Ketoconazole	Ketoconazole	30	14
Tizanidine Hcl	Tizanidine Hcl	30	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	30	suppressed
Advocate Pen Needles	Pen Needle, Diabetic	29	18
Tradjenta	Linagliptin	28	suppressed
Digoxin	Digoxin	27	suppressed
Icosapent Ethyl	Icosapent Ethyl	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Breyna	Budesonide/Formoterol Fumarate	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	11
Donepezil Hcl	Donepezil Hcl	26	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Fenofibrate	Fenofibrate,micronized	25	suppressed
Olanzapine	Olanzapine	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	24	suppressed
Oxcarbazepine	Oxcarbazepine	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Felodipine Er	Felodipine	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	22	22
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	15
Glipizide	Glipizide	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Tresiba Flextouch U-100	Insulin Degludec	21	suppressed
Dexlansoprazole Dr	Dexlansoprazole	20	suppressed
Dulera	Mometasone/Formoterol	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Calcitriol	Calcitriol	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	18
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	19	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	19	suppressed
Acarbose	Acarbose	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	12
Hydrocortisone	Hydrocortisone	18	11
Myrbetriq	Mirabegron	18	suppressed
Clotrimazole	Clotrimazole	17	11
Creon	Lipase/Protease/Amylase	17	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	17	suppressed
Mupirocin	Mupirocin	17	12
Shingrix	Varicella-Zoster Ge/As01b/Pf	16	14
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Azithromycin	Azithromycin	15	14
Bethanechol Chloride	Bethanechol Chloride	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Nateglinide	Nateglinide	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Budesonide	Budesonide	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Cephalexin	Cephalexin	13	13
Chlorthalidone	Chlorthalidone	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Movantik	Naloxegol Oxalate	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Risperidone	Risperidone	12	suppressed
Advocate Pen Needle	Pen Needle, Diabetic	11	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Nystatin	Nystatin	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	11	suppressed
Zenpep	Lipase/Protease/Amylase	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error